14 / 76
“We believe that immunotherapy
is and will continue to be a giant
leap forward in the treatment of
cancer,” says Tony Traub. Tony is an
entrepreneur who has spent much
of his career in the financial services
industry. Together with his wife
Wendy, they recognized that The
Princess Margaret has a world class
team in the area of immunotherapy,
and wanted to help move their
initiatives forward.
Tony andWendy are excited about
the potential that lies ahead with
Personalized Cancer Medicine, and
they want to be part of making it
a reality. They decided this year to
make a significant investment to help
accelerate the Tumor Immunotherapy
Program at Princess Margaret Cancer
Centre, bringing their total giving to
$1 million.
Wendy is currently a patient at the
cancer centre. She was diagnosed
with melanoma in July 2014—the
same month in which they lost a
dear friend to brain cancer. Wendy’s
melanoma was quickly removed,
but it recurred. Today, she is in the
care of Dr. Marcus Butler, a medical
oncologist, and his team.
Wendy is receiving immunotherapy
and being cared for by the staff at
The Princess Margaret. She feels
fortunate to be in the hands of one
of the physicians leading the Tumor
Immunotherapy Program.
“This generous gift fromWendy and
Tony Traub will help us immensely
in moving the knowledge of our
immune system gained in our
laboratories into the clinic where it
can benefit patients directly,” says
Dr. Butler. “For example, The Princess
Margaret is establishing an Immune
Monitoring Laboratory which will
play a key role in understanding why
certain patients benefit from the new
immunotherapies while others do not.”
Wanting to be part of a
‘giant leap forward in the
treatment of cancer’
10
2016 Report to Our Donors